Sharechat Logo

AXA earnings fall

Wednesday 6th August 2008

Text too small?
AXA New Zealand, the country's biggest fund manager for individuals, posted an 11% drop in operating profit on reduced earnings from wealth management and costs to install new operating systems.

Operating earnings fell to NZ$27.1 million in the six months ended June 30, from NZ$30.6 million a year earlier, the company said in a statement. AXA KiwiSaver funds under management surged to NZ$79 million from NZ$23 million.

The results reflect "AXA's strength in a challenging external environment," chief executive Ralph Stewart said.

The fund manager this week suspended wholesale withdrawals from its NZ$229 million mortgage-backed bond fund and warned it may extend the freeze to small investors to prevent a run on funds that would undermine liquidity.

AXA New Zealand's operating earnings from wealth management fell to NZ$7.3 million from NZ$10.2 million. Earnings from insurance fell to NZ$19.8 million from NZ$20.4 million. Total management expenses rose 12% on investment in new operating systems, it said.

Yesterday, shares of parent Axa Asia Pacific Holdings jumped 7.2% after the Australian company said earnings excluding investments rose 11%.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors